| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2007 | WO2007005058A2 Monoazole ligand platinum analogs |
| 01/11/2007 | WO2007005056A2 Platinum complexes with mononitrile-containing ligands |
| 01/11/2007 | WO2007004975A1 Heparin coating of biological tissue |
| 01/11/2007 | WO2007004960A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007004958A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
| 01/11/2007 | WO2007004957A1 Novel crystalline form |
| 01/11/2007 | WO2007004952A1 Antimicrobial and antiinflammatory composition |
| 01/11/2007 | WO2007004912A1 Allergen |
| 01/11/2007 | WO2007004749A1 Fused heterocyclic derivatives and use thereof |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004715A1 Method and composition to individualize levodopa/carbidopa therapy using a breath test |
| 01/11/2007 | WO2007004705A1 Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 01/11/2007 | WO2007004692A1 Prophylactic/therapeutic agent and diagnostic agent for non-small cell lung cancer |
| 01/11/2007 | WO2007004689A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/11/2007 | WO2007004688A1 Xanthine oxidase inhibitor |
| 01/11/2007 | WO2007004685A2 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/11/2007 | WO2007004675A1 Drug-containing photocrosslinked hyaluronic acid derivative gel |
| 01/11/2007 | WO2007004621A1 Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent |
| 01/11/2007 | WO2007004613A1 THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-α PRODUCTION INHIBITOR |
| 01/11/2007 | WO2007004587A1 Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, malignant tumor cell suppressive viral vector, and kit using the same |
| 01/11/2007 | WO2007004570A1 Composition having physical endurance improving effect and/or anti-fatigue effect |
| 01/11/2007 | WO2007004545A1 Nanocarbon-supported object, process for producing the same, and drug for dds comprising the same |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007004523A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 01/11/2007 | WO2007004510A1 Pharmaceutical for use in the treatment of cerebral infarction |
| 01/11/2007 | WO2007004425A1 Tablet containing poorly soluble active ingredient |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007004239A1 New polymorphic form of sultamicillin tosylate and a process therefor |
| 01/11/2007 | WO2007004236A2 Improved drug or pharmaceutical compounds and a preparation thereof |
| 01/11/2007 | WO2007004061A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/11/2007 | WO2007004049A1 Oxazolidinones containing azetidine as antibacterial agents |
| 01/11/2007 | WO2007004038A1 Aminothiazole derivatives as agonists of the thrombopoietin receptor |
| 01/11/2007 | WO2007004037A1 Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| 01/11/2007 | WO2007004032A1 Oxazolidiones containing cyclobutane as antibacterial agents |
| 01/11/2007 | WO2007003972A1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
| 01/11/2007 | WO2007003963A1 Zofenopril calcium in polymorph form c |
| 01/11/2007 | WO2007003960A1 Gpcr agonists |
| 01/11/2007 | WO2007003957A2 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | WO2007003948A2 Core 2 glcnac-t inhibitors |
| 01/11/2007 | WO2007003941A1 Modulation of autophagy by calpain inhibition |
| 01/11/2007 | WO2007003933A2 Combination therapy of cancer with azd2171 and gemcitabine |
| 01/11/2007 | WO2007003896A1 The treatment of inflammatory disorders and pain |
| 01/11/2007 | WO2007003768A2 Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition |
| 01/11/2007 | WO2007003767A2 Novel chemical compounds and the uses thereof as a medicine |
| 01/11/2007 | WO2007003765A1 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 01/11/2007 | WO2007003746A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 01/11/2007 | WO2007003741A2 Polyphenol type compounds, compositions containing same and use thereof for preventing or treating diseases involving abnormal cell proliferation |
| 01/11/2007 | WO2007003611A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
| 01/11/2007 | WO2007003596A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | WO2007003594A1 Screening methods for inhibitors of the metalloprotease meprin |
| 01/11/2007 | WO2007003581A1 Phenoxy acetic acids as ppar delta activators |
| 01/11/2007 | WO2007003554A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance. |
| 01/11/2007 | WO2007003543A1 Method for producing an aqueous suspension and a powdered preparation of one or more carotinoids |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2007003521A2 Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/11/2007 | WO2007003481A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 01/11/2007 | WO2007003435A2 Use of activators of the soluble guanylate cyclase for promoting the healing of wounds |
| 01/11/2007 | WO2007003422A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 01/11/2007 | WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | WO2007003386A1 Imidazopyridine derivatives as acid pump antagonists |
| 01/11/2007 | WO2007003385A1 Oral composition comprising dimethicone copolyol |
| 01/11/2007 | WO2007003365A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | WO2007003308A1 Substituted quinolones ii |
| 01/11/2007 | WO2007003289A1 Skin-lightening compositions with an improved action |
| 01/11/2007 | WO2007003204A1 Topical formulation for the treatment of ano-rectal diseases |
| 01/11/2007 | WO2007003200A2 High yield synthesis methods for producing organic salts of strontium |
| 01/11/2007 | WO2007003077A1 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 01/11/2007 | WO2007003056A1 Cathepsin cysteine protease inhibitors |
| 01/11/2007 | WO2007003054A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 01/11/2007 | WO2007003020A1 Oral formulations comprising ondansetron and a highly dosed sweeten |
| 01/11/2007 | WO2007003007A1 Methods and compositions for improving pregnancy outcome |
| 01/11/2007 | WO2007002988A1 Formulation of microbial pesticides |
| 01/11/2007 | WO2007002973A2 Use of stilbene derivatives for the production of medicaments for the treatment of solid tumours |
| 01/11/2007 | WO2006129178A8 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 01/11/2007 | WO2006128009A3 Supplement composition and method of use for enhancement of dna repair process |
| 01/11/2007 | WO2006127399A3 Versatile high load concentrate compositions comprising metaflumizone for control of ecto-parasites |
| 01/11/2007 | WO2006125285B1 Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
| 01/11/2007 | WO2006124865A3 Biaryls derivatives useful as modulators of ion channels |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006123226A3 An inhibitor of mtor for inhibiting the formation of scar tissue |
| 01/11/2007 | WO2006123182A3 Cyclohexyl sulphones for treatment of cancer |
| 01/11/2007 | WO2006121941A3 Pharmaceutical compositions comprising imatinib and a release retardant |
| 01/11/2007 | WO2006121421A8 Methods and formulations for treating glaucoma |
| 01/11/2007 | WO2006121390A3 Benzoic acid derivatives that are modulators or agonists of glyr |
| 01/11/2007 | WO2006120481A3 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 01/11/2007 | WO2006120465A3 Therapeutic sclerosing foam made preferably xenon |
| 01/11/2007 | WO2006119284A3 Conjugated aromatic compounds for diagnosis and therapy |
| 01/11/2007 | WO2006118871A3 Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis |
| 01/11/2007 | WO2006117220A3 Method of administering a cationic liposomal preparation comprising paclitaxel |
| 01/11/2007 | WO2006116485A3 Trpv1 agonist compounds and methods for making and using the same |
| 01/11/2007 | WO2006114019A8 Polysaccharide extract from lycium barbarum as neuroprotective agent against beta-amyloid peptide neurotoxicity |
| 01/11/2007 | WO2006113571B1 Substituted cyclopentanones for treating inflammatory bowel disease |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006113151A3 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients |
| 01/11/2007 | WO2006106519A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 01/11/2007 | WO2006103206A3 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 01/11/2007 | WO2006102535A3 Sulfonyl containing compounds as cysteine protease inhibitors |